key: cord-0810439-y0uv08oy
authors: Bascetta, Thomas; Bolton, Lauri; Kurtzman, Ethan; Hantzos, William; Standish, Heather; Margarido, Patricia; Race, Kathleen; Spencer, John; Baker, William; Gluck, Jason
title: Air Medical Transport of Patients Diagnosed with Confirmed COVID-19 Infection Undergoing Extracorporeal Membrane Oxygenation (ECMO). A Case Review and Lessons Learned
date: 2020-11-28
journal: Air Med J
DOI: 10.1016/j.amj.2020.11.015
sha: 37622310337c42d370ceb371081703c47a1d909e
doc_id: 810439
cord_uid: y0uv08oy

The COVID-19 pandemic disrupted healthcare delivery in every respect, including critical care resources and transport of patients requiring Extracorporeal Membrane Oxygenation (ECMO). Innovative solutions allowing for safe helicopter air transport of these critical patients is needed as ECMO resources are only available in specialty centers. We present a case demonstrating the interfacility collaboration of care for a patient with COVID-19 infection and the lessons learned from the air transport. Careful planning, coordination, communication, and teamwork contributed to the safe transport of this patient, and several others subsequently.

The COVID-19 pandemic has significantly disrupted the planet, and the critical care transport community is not immune. The efficacy of ECMO support, both VV and VA has been carefully studied throughout the COVID-19 pandemic. While early evidence shows that there is some benefit to patients infected with COVID-19 who receive early ECMO support for persistent ARDS or pneumonia, many unknowns still exist. 1, 2 Air rotary wing critical care transport programs evolved and pivoted to ensure safety for both patients and crews while providing high quality critical care for patients. Through "ECMO-on-the-Go," collaboration between Hartford HealthCare's Heart and Vascular Institute and LIFE STAR, our air medical program, we are able to provide primary ECMO capabilities, when patients deemed too unstable for interfacility transfer can have ECMO implanted at the sending center for stabilization with subsequent transfer to a tertiary care center, to COVID-19 patients with severe respiratory failure.

While descriptions of ground medical transport of critically ill COVID-19 positive adults exist, patients undergoing primary Extracorporeal Membrane Oxygenation (ECMO) therapy for COVID-19 infection are moved by helicopter are not described and offer unique challenges. This report describes our first rotary wing air medical transport of a COVID-19 positive patient who underwent primary ECMO at a remote site and was transferred to a tertiary care center by helicopter and our lessons learned.

A 43 year old male with Diabetes Mellitus Type II presented with dyspnea and diagnosed with COVID-19 pneumonia. Over several days his respiratory status decompensated with worsening hypercarbic and hypoxic respiratory failure despite aggressive therapy including intubation, prone positioning, high PEEP ventilation, paralytics, and inhaled pulmonary vasodilator use. The ECMO-on-the-Go team was consulted and the patient deemed an appropriate candidate for venovenous (V-V) ECMO therapy. Unfortunately, there were no local ECMO centers available to accept this patient, and the closest accepting center was 150 miles away.

This was a scenario previously considered by the ECMO-on-the-Go team and preparations for such an event were already in place. Prior to making patient contact the team addressed all variables, logistics and anticipated challenges associated with the transport. It was decided among the pilot, air medical crew, and ECMO team that the patient could be safely transported by air to the receiving facility.

On arrival to the patient's bedside, the insertion team (ECMO physician lead/implanter, Perfusionist and LIFE STAR Air Medical Crew (RN Paramedic, RT Paramedic, or Paramedic)) found him intubated and supine in bed. His oxygen saturations were in the low 90's despite a PEEP of 22 cmH20 and FiO 2 100%. ABG on arrival was 7.29, pCO 2 52, pO 2 54 on VC/AC RR 22, V T 480, PEEP 22 cmH20, FiO 2 100%. He was tachycardic with labile blood pressures of 80/40mmHg despite a norepinephrine infusion. Propofol and fentanyl were infusing for sedation and analgesia as was inhaled epoprostenol for oxygenation. ECMO support was initiated by the ECMO on the Go team via inflow cannula from the right femoral vein (24F end hole) and outflow cannula to the right internal jugular vein (19F arterial cannula). Initial ECMO flows were 5.5 LPM with a sweep of 6 LPM. Once on ECMO, the heart rate decreased and the blood pressure increased, with resultant downward titration of norepinephrine. Oxygen saturation increased to 100% and remained between 96% and 100% throughout transport. Post ECMO ABG was 7.43 PCO 2 37, pO 2 109 on PCV/AC RR 12, DP 28 (V T approx. 250ml), PEEP 15 cmH20, FiO 2 80%. The patient was transitioned to hydromorphone and lorazepam infusions for sedation and analgesia while the patient was prepared for transport.

The team, taking appropriate PPE precautions, transferred the patient and associated medical equipment to the helicopter stretcher. Careful consideration was taken when moving the patient to ensure that decannulation did not occur with manual stabilization of the cannula sites during position changes. The patient and associated medical equipment was wrapped in plastic bags to minimize contamination and secured into the aircraft in preparation for flight. In addition to the air medical crew, the physician and perfusionist escorted the patient to the receiving center.

Enroute to the receiving facility the patient was monitored and critically stable. Heart rate remained in the 60's, SBP in the 140's and DBP in the 60's despite reduction in norepinephrine dose, and SpO 2 remained 96%-100%. He required no further interventions. Upon arrival to receiving facility the patient was offloaded and brought to the ICU where the transition of care occurred without issue.

Once patient handoff was completed, decontamination of all equipment began in a predetermined decontamination area. All surfaces of the stretcher, monitor, ventilator, and ECMO console were thoroughly wiped down with disinfectant wipes according to our Infectious Disease Department and the manufacturer's recommendations. Once completed the crew went to the rooftop to decontaminate the aircraft. All doors to the aircraft were left open while the patient was being transferred to the receiving ICU, allowing for approximately 45 minutes of ventilation of the aircraft. The entire interior was wiped down with disinfectant wipes and allowed to dry. Once decontamination was complete, all equipment was secured in the aircraft in the usual fashion. The return leg was then completed without incident.

On follow up, the patient received a tracheostomy for short-term ventilator support and was subsequently weaned from ECMO, decannulated from his tracheostomy and ultimately discharged home.

To our knowledge, this is the first reported case of discussing out of hospital transport of COVID-19 positive patients undergoing ECMO therapy by rotary wing aircraft. ECMO is successful in supporting patients during transport in cases of Acute Respiratory Distress Syndrome (ARDS) as well as other disease processes, both cardiac and pulmonary in nature . The medical community infers that ECMO therapy may be beneficial in COVID-19 infected patients who are demonstrating cardiopulmonary deficiencies as a result of the infection and have reported its use . As the FDA has offered expanded use of ECMO during the COVID-19 pandemic, we can anticipate more patients being placed on ECMO support and needing transport to tertiary centers 58 .

The LIFE STAR air medical program, in collaboration with the Heart and Vascular Institute at Hartford HealthCare, continually refines its practice to optimize efficiency and safety during the transport. This service allows primary ECMO availability to patients otherwise too unstable for transport to tertiary and quaternary care.

At the time of submission, we have transported 101 patients undergoing ECMO therapy, with the majority of these transports being by ground ambulance. Recently, we started transporting appropriately selected ECMO patients by helicopter after demonstrating its feasibility using high fidelity simulation. To date we have flown 20 ECMO patients (of which 8 were COVID positive) successfully utilizing procedures developed in this process.

Utilizing air medical transport for ECMO patients is operationally challenging. Adding the factor of a highly infectious disease such as COVID-19 only increases the complexity of transport. After retrospectively reviewing our series of 8 COVID-19 ECMO helicopter transports thus far, there are several factors that we believe are essential to safely transporting these patients.

Central coordination is paramount in timely and safe patient evaluation and transport. Key factors include succinct and effective communication regarding team and hospital capabilities, clinical information, and coordination among service lines (air medical, physician, perfusion and ground EMS when needed). A central Care Logistics Center is an effective means to achieve this degree of communication coordination. In our system, LIFE STAR's Emergency Communication Center works in parallel to determine which air medical crew is available and coordinate transportation based on the unique factors of the request.

Prior to every ECMO transport a secure email containing patient information is sent to the team. After the team air medical team reviews the patient document, a conference call with the pilot, communications center, and ECMO physician occurs. Together, a determination is made on best strategies for team insertion and patient retrieval (ground vs. air).

Several factors such as transport time, resource availability, duty hours and patient condition are considered. If air transport is deemed beneficial, the pilot performs a weather check to determine air transport feasibility. If appropriate, the weights of the team, patient and equipment are used to determine helicopter weight and balance for successful mission completion. Only then, after all factors are considered, is the final determination of air mission acceptance rendered.

In light of COVID-19 other factors also need to be considered once a mission is accepted for air transport; ensuring we have enough PPE for the additional transport personnel, plastic bags to cover soft surfaces and prevent contamination, and a timeline of when pickup should occur are some of these mission-specific factors.

It is essential to minimize contamination of equipment and efficiently decontaminate the aircraft to ensure timely return to operational service. We utilized plastic bags to cover potentially needed equipment that was not in use prior to departure from the bedside. This also diminished the time required for post transport decontamination. At the end of the transport, the used disposable equipment is discarded and any reusable equipment disinfected.

All team members at the patient's bedside are donned in full PPE when transitioning the patient over from the hospital equipment to the transport equipment and preparing them for transport. It was decided that the most efficient way to complete the transition would be to divide the air medical crew.

During the implant process, one team member tends to the patient and readies them for transport while the other remains outside of the room to access and hand-off additional needed equipment. We designated this outside crew member as the "clean crewmember," meaning that this person would not enter the isolation room, thereby decreasing exposure. Additionally, this eliminated unnecessary compromise of clean supplies and minimized donning and doffing of scarce PPE. Moreover, it reduced the risk of an accidental self-contamination/exposure, as donning and doffing PPE properly can be challenging at times and creates an opportunity for selfcontamination.

We chose the crewmember who rides the front of the aircraft, apart from the patient and ECMO team, to remain clean so the person caring for the patient may configure the aircraft in the most efficient manner possible (Figure 1 ). The clean crewmember kept potentially needed items with them to be handed back to their partner if necessary such as push dose medications and controlled substances.

We developed a visual guide to standardize where things can be safely secured (Figure 1 ). Aside from effectively securing all items for transport, a major goal was minimizing contamination of equipment and personnel.

Prior to the mission we remove unnecessary equipment from the back of the aircraft (this includes our ultrasound, trauma pack and PFD bag), reducing equipment vulnerable to contamination. All equipment bags were wrapped in plastic bags and secured to the floor. Anticipated equipment and medications are with the clean crewmember in front, reducing the likelihood of opening a plastic bag and decreasing contamination risk. All carrying cases for equipment were removed, allowing for easier cleaning and decreasing the need for laundering post transport. 

The COVID-19 ECMO transport by air is a dynamic process that is continually improving. The post transport debrief is essential to process improvement. Lessons learned and meaningful solutions were quickly identified and assimilated by the team for the next mission.

Our administrator on call is also debriefed so operational issues on an administrative level are quickly addressed.

The COVID-19 pandemic presents unique challenges to the transportation of critically ill patients, particularly those requiring primary ECMO. With careful planning, coordination, communication, and teamwork, COVID-19 patients can be safely transported by helicopter.

Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure

Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?

Interhospital transfer of seriously sick ARDS patients using veno-venous Extracorporeal Membrane Oxygenation (ECMO): Concept of an ECMO transport team

Inter-hospital transportation of patients with severe acute respiratory failure on extracorporeal membrane oxygenation--national and international experience

A review of 100 patients transported on extracorporeal life support

Extracorporeal circulatory systems in the interhospital transfer of critically ill patients: experience of a single institution

Logistics and safety of extracorporeal membrane oxygenation in medical retrieval

Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience

The introduction of extracorporeal membrane oxygenation to aeromedical evacuation

First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport

Extracorporeal membrane oxygenator rescue and airborne transportation of patients with influenza A (H1N1) acute respiratory distress syndrome in a Mediterranean underserved area

Session UMAC/UMAR: point de vue du SMUR, évaluation des coûts [MCAU/MRAU session: point of view of the pre-hospital

Venovenous extracorporeal membrane oxygenation for acute lung failure in adults

First experience with the new portable extracorporeal membrane oxygenation system Cardiohelp for severe respiratory failure in adults

The French airbridge for circulatory support in the Carribean

Transfert interhospitalier sous assistance circulatoire extracorporelle (ECMO): l'expérience martiniquaise

First experience with the deltastream(R) DP3 in venovenous extracorporeal membrane oxygenation and air-supported inter-hospital transport

Interhospital air transport of a blind patient on extracorporeal life support with consecutive and successful left ventricular assist device implantation

The Stockholm experience: interhospital transports on extracorporeal membrane oxygenation

Maternal and Fetal Recovery After Severe Respiratory Failure: A Case Report of Air Transportation of a Pregnant Woman on ECMO Using the CentriMag Transporter System

Aeromedical Evacuation Using Extra Corporeal Life Support After Resuscitated Cardiac Arrest

Transport While on Extracorporeal Membrane Oxygenation Support

Remote ECLS-Implantation and Transport for Retrieval of Cardiogenic Shock Patients

Adverse Events during Inter-Hospital Transports on Extracorporeal Membrane Oxygenation

Characterization of patients transported with extracorporeal respiratory and/or cardiovascular support in the State of São Paulo, Brazil. Caracterização de pacientes transportados com suporte respiratório e/ou cardiovascular extracorpóreo no Estado de São Paulo − Brasil

Retrieval of critically ill adults using extracorporeal membrane oxygenation: the nine-year experience in New South Wales

Interhospital transport of ARDS patients on extracorporeal membrane oxygenation

Safety and Flight Considerations for Mechanical Circulatory Support Devices During Air Medical Transport and Evacuation: A Systematic Narrative Review of the Literature

Outcome of inter-hospital transfer of patients on extracorporeal membrane oxygenation in Switzerland

First report about a successful ECLS implantation and subsequent helicopter transfer of a super obese patient with a BMI of 78 kg/m2

Extracorporeal Membrane Oxygenation in Transport Part 2: Complications and Troubleshooting

Extracorporeal Membrane Oxygenation as Treatment of Severe COVID-19 Infection: A Case Report

Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report

Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan

Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A "Living Working Document

Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?

COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review

Zhejiang Da Xue Xue Bao Yi Xue Ban

Extracorporeal Membrane Oxygenation for Coronavirus Disease

Emelt szintű szervtámogató és életfenntartó kezelések kritikus állapotú COVID-19-fertőzött betegeken [Organ replacement therapy and life-supporting treatment modalities

Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report

SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy

Chinese Society of Extracorporeal Life Support

First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report

COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support

A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report

The role of extracorporeal life support for patients with COVID-19: Preliminary results from a statewide experience

Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience

Utility of extracorporeal membrane oxygenation in COVID-19

Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO)

Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients

Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study

Extracorporeal Membrane Oxygenation for Pediatric Patients With Coronavirus Disease 2019-Related Illness

The role of ECMO in COVID-19: Can it provide rescue therapy in those who are critically ill

Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America

FDA offers expanded use for ECMO, cardiopulmonary bypass and ophthalmic devices amid COVID-19